Global Amylase Activity Assay Kit Market Strategic Research Report
By Type: Colorimetric Assay, Fluorometric Assay, Luminescent Assay
By Application: Research Grade Assay Kit, Preclinical Diagnostic Kit, Automation-Compatible Assay Kit
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Merck, Thermo Fisher Scientific Inc., New England Biolabs, Bio-Techne Corporation, GenScript, AMSBIO, ACROBiosystems Group, Nanjing Vazyme Biotech Co., Ltd., Sino Biological, Inc., RayBiotech, Inc., Novoprotein Scientific Inc., TransGen Biotech, Enzynomics, Yisheng Biotechnology (Shanghai) Co., Ltd., ProSpec, Shanghai Biyuntian Biotechnology Co., Ltd.
概観
Scope of the Report
The global Amylase Activity Assay Kit market size is predicted to grow from US$ 202 million in 2025 to US$ 399 million in 2032; it is expected to grow at a CAGR of 10.4% from 2026 to 2032.
Amylase activity assay kits are biochemical assay products used to quantitatively determine the catalytic activity of amylases (α-amylase or total amylase) in samples. Measurements are typically based on changes in reducing sugars, colorimetric products, or absorbance produced after starch or its derivative substrates are hydrolyzed by the enzyme. These kits generally contain a specific substrate, reaction buffer, chromogenic agent, and standards. Enzyme activity units can be rapidly calculated using spectrophotometry or colorimetry. They are widely used in clinical diagnostics (such as pancreatic function assessment), quality control in the food and fermentation industries, and biochemistry teaching and research experiments. They are a commonly used standardized tool for assessing amylase function and activity levels. In 2025, sales volume was 560,000 units, with an average price of US$335 per unit. Total production capacity was 650,000 units, with a gross profit margin of 82%.
Global key Amylase Activity Assay Kit players cover Merck, Thermo Fisher Scientific Inc., New England Biolabs, Bio-Techne Corporation, GenScript, etc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Amylase Activity Assay Kit market?
What factors are driving Amylase Activity Assay Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amylase Activity Assay Kit market opportunities vary by end market size?
How does Amylase Activity Assay Kit break out by Type, by Application?
This report presents a comprehensive overview of the global Amylase Activity Assay Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Colorimetric Assay
- Fluorometric Assay
- Luminescent Assay
Segment by Enzyme Type
- α-Amylase Activity Assay Kit
- Total Amylase Activity Assay Kit
- Amylase Assay Kit
Segment by Application
- Medical Biology
- Laboratory
- Others
Segment by Application
- Research Grade Assay Kit
- Preclinical Diagnostic Kit
- Automation-Compatible Assay Kit
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Amylase Activity Assay Kit market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Research Grade Assay Kit, Preclinical Diagnostic Kit, Automation-Compatible Assay Kit evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Amylase Activity Assay Kit Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Colorimetric Assay
- 3.1.3 Fluorometric Assay
- 3.1.4 Luminescent Assay
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Research Grade Assay Kit
- 4.1.3 Preclinical Diagnostic Kit
- 4.1.4 Automation-Compatible Assay Kit
- 4.1.5 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Merck
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Thermo Fisher Scientific Inc.
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 New England Biolabs
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Bio-Techne Corporation
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 GenScript
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 AMSBIO
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 ACROBiosystems Group
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Nanjing Vazyme Biotech Co., Ltd.
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Sino Biological,Inc.
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 RayBiotech, Inc.
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Novoprotein Scientific Inc.
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 TransGen Biotech
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Enzynomics
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Yisheng Biotechnology (Shanghai) Co., Ltd.
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 ProSpec
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Shanghai Biyuntian Biotechnology Co., Ltd.
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the size of the global Amylase Activity Assay Kit market?
What is the forecast CAGR for the Amylase Activity Assay Kit market?
What is Amylase Activity Assay Kit?
How is the Amylase Activity Assay Kit market segmented by type?
What are the key applications of Amylase Activity Assay Kit?
Which companies are profiled in the Amylase Activity Assay Kit market report?
What geographies does the Amylase Activity Assay Kit market analysis include?
What are the key demand drivers for Amylase Activity Assay Kit?
Who should buy the Amylase Activity Assay Kit market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Related reports
Navadhi Market Research · Healthcare & Medical DevicesGlobal Wireless Infusion Pump Safety Market Strategic Research Report
The global wireless infusion pump safety market occupies a critical intersection of medical device technology, patient safety infrastructure, and hospital informatio…
Navadhi Market Research · Healthcare & Medical DevicesGlobal Smart Medical Waste Segregation Market Strategic Research Report
The global smart medical waste segregation market occupies a critical intersection of healthcare-industry-strategic-research-report" title="Global Healthcare Industr…
Navadhi Market Research · Healthcare & Medical DevicesGlobal Microfluidic Point of Care Diagnostics Market Strategic Research Report
The global microfluidic point of care (POC) diagnostics market represents one of the most commercially consequential intersections of materials science, biomedical e…
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Amylase Activity Assay Kit Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Leading Brands in This Industry
